Tsengelmaa Jamiyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tsengelmaa Jamiyan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Ai Koyanagi
Department of Diagnostic Pathology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan
1 shared publication- Akihito Abe
Patient Safety and Pharmacovigilance Japan, Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan
1 shared publication Akinari Kakumoto
Department of Diagnostic Pathology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan
1 shared publicationAnand Altankhuyag
Department of Immunology, School of Bio-Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
1 shared publication- Anujin Tseveenjav
Department of Pathology and Forensic Medicine, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
1 shared publication - Ariunzaya Bat-Erdene
Department of Immunology, School of Bio-Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 2 (19) , 1974-1990
Anti-inflammatory and Lung Protective Effect of the Herbal Formulation on LPS-induced Acute Lung Injury Model
Herbal products are considered important medicinal sources in both traditional medicine and modern pharmacology. Our study examined the lung-protective and anti-inflammatory properties of the herbal formulation in alipopolysaccharide (LPS)induced model of acute lung injury. Non-cytotoxic concentrations in cells were evaluated in vitrousing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and analysis of nitric oxide (NO) production. In our invivo study, acute lung inflammation was induced in experimental animals by LPS. Treatment with the herbal formulation notably decreased NO production, increased superoxide dismutase (SOD) levels, and reduced the protein levels of tumor necrosis factor-alpha (TNF-α) and high-mobility group box 1 (HMGB1). Furthermore, histopathological studies confirmed its protective effects against LPS-induced lung inflammation. Molecular docking revealed that glycyrrhizic acid and inulin interact strongly with TNF-α and HMGB1 proteins, supporting their potential to mediate the observed anti-inflammatory effects.In conclusion, the herbal formulation demonstrates anti-inflammatory and lung-protective properties, suggesting its potential efficacy in mitigating LPS-induced acute lung injury.
- 25 June 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 2 (19) , 1974-1990
Open AccessAnti-inflammatory and Lung Protective Effect of the Herbal Formulation on LPS-induced Acute Lung Injury Model
Herbal products are considered important medicinal sources in both traditional medicine and modern pharmacology. Our study examined the lung-protective and anti-inflammatory properties of the herbal formulation in alipopolysaccharide (LPS)induced model of acute lung injury. Non-cytotoxic concentrations in cells were evaluated in vitrousing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and analysis of nitric oxide (NO) production. In our invivo study, acute lung inflammation was induced in experimental animals by LPS. Treatment with the herbal formulation notably decreased NO production, increased superoxide dismutase (SOD) levels, and reduced the protein levels of tumor necrosis factor-alpha (TNF-α) and high-mobility group box 1 (HMGB1). Furthermore, histopathological studies confirmed its protective effects against LPS-induced lung inflammation. Molecular docking revealed that glycyrrhizic acid and inulin interact strongly with TNF-α and HMGB1 proteins, supporting their potential to mediate the observed anti-inflammatory effects.In conclusion, the herbal formulation demonstrates anti-inflammatory and lung-protective properties, suggesting its potential efficacy in mitigating LPS-induced acute lung injury.
- Open Access
- 1 February 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e950318
Subcutaneous Solitary Fibrous Tumor in the Chin of a Young Adult: A Diagnostic Challenge
BACKGROUND Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms most commonly originating in the pleura but may also arise in extrapleural sites, including the head and neck region. Subcutaneous SFTs in the chin area are exceptionally rare; only a few cases have been reported. CD34 and Bcl-2 are commonly used immunohistochemical markers in the initial diagnostic workup, and their co-expression is strongly suggestive of an SFT. However, CD34 negativity can be misleading and complicate diagnosis. Accurate identification of SFTs is potentially difficult because of histologic variability and overlap with other spindle cell tumors. CASE REPORT We encountered a rare subcutaneous SFT in the chin of a 22-year-old woman who presented with facial asymmetry and a tender mass. Imaging revealed a well-circumscribed, contrast-enhancing lesion in subcutaneous soft tissue over the anterior mandible. Histologically, the tumor lacked typical staghorn vasculature but showed spindle cell proliferation within a fibrous stroma. Immunohistochemistry demonstrated strong nuclear STAT6 positivity; expression of CD99, Bcl-2, and SMA; and focal H-caldesmon staining. CD34, S100, and ALK1 displayed negative staining. Based on these findings, the patient was diagnosed with an SFT. CONCLUSIONS This case highlights the importance of considering SFT in the differential diagnosis of spindle cell tumors in the head and neck region. It also underscores the critical role of immunohistochemistry, particularly STAT6 staining, in distinguishing SFT from histologic mimics. Vigilant follow-up remains essential, especially in atypical or CD34-negative cases, given their potential for aggressive behavior.
- 1 February 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e950318
Open AccessSubcutaneous Solitary Fibrous Tumor in the Chin of a Young Adult: A Diagnostic Challenge
BACKGROUND Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms most commonly originating in the pleura but may also arise in extrapleural sites, including the head and neck region. Subcutaneous SFTs in the chin area are exceptionally rare; only a few cases have been reported. CD34 and Bcl-2 are commonly used immunohistochemical markers in the initial diagnostic workup, and their co-expression is strongly suggestive of an SFT. However, CD34 negativity can be misleading and complicate diagnosis. Accurate identification of SFTs is potentially difficult because of histologic variability and overlap with other spindle cell tumors. CASE REPORT We encountered a rare subcutaneous SFT in the chin of a 22-year-old woman who presented with facial asymmetry and a tender mass. Imaging revealed a well-circumscribed, contrast-enhancing lesion in subcutaneous soft tissue over the anterior mandible. Histologically, the tumor lacked typical staghorn vasculature but showed spindle cell proliferation within a fibrous stroma. Immunohistochemistry demonstrated strong nuclear STAT6 positivity; expression of CD99, Bcl-2, and SMA; and focal H-caldesmon staining. CD34, S100, and ALK1 displayed negative staining. Based on these findings, the patient was diagnosed with an SFT. CONCLUSIONS This case highlights the importance of considering SFT in the differential diagnosis of spindle cell tumors in the head and neck region. It also underscores the critical role of immunohistochemistry, particularly STAT6 staining, in distinguishing SFT from histologic mimics. Vigilant follow-up remains essential, especially in atypical or CD34-negative cases, given their potential for aggressive behavior.
- Open Access
- 26 May 2020
- Published by Elsevier in Human Pathology: Case Reports
- Vol. 20, 200383
Ductal carcinoma in situ of the breast with osteoclast-like giant cells: A case report with immunohistochemical analysis
- 26 May 2020
- Published by Elsevier in Human Pathology: Case Reports
- Vol. 20, 200383
Open AccessDuctal carcinoma in situ of the breast with osteoclast-like giant cells: A case report with immunohistochemical analysis